相关实验视频

Updated: Jun 23, 2025

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Published on: December 4, 2015

RNA聚合酶III参与调节Plasmodium falciparum病毒性的作用

Gretchen Diffendall^1,2, Aurelie Claes¹, Anna Barcons-Simon^1,2,3

¹Institut Pasteur, Universite Paris Cité, Paris, France.

|June 26, 2024

概括

持久无症状疟疾是一个公共卫生问题,与Plasmodium falciparum中的RNA聚合酶III (RNA Pol III) 转录减少有关. 这种下调影响了寄生虫的毒性和季节性感染模式.

科学领域:

分子寄生虫学分子寄生虫学
传染性疾病传染性疾病
基因规则基因规则

背景情况:

季节性无症状疟疾感染是一个重大的全球卫生挑战,往往没有被发现和治疗.
疟疾的疾病严重程度与感染红细胞 (iRBC) 粘附有关,但在无症状感染期间导致粘附能力变化的机制尚不清楚.
致使严重疟疾的寄生虫Plasmodium falciparum表现出复杂的调节机制,影响其毒性和宿主相互作用.

研究的目的:

在季节性无症状疟疾感染期间研究RNA聚合酶III (RNA Pol III) 转录在Plasmodium falciparum中的作用.
阐明RNA Pol III活动影响寄生虫繁殖和毒性因子表达的分子机制.
确定P. falciparum中RNA Pol III转录的关键调节者及其与无症状感染动态的联系.

主要方法:

在干旱季节从无症状个体的P. falciparum野外分离物中分析RNA Pol III转录水平.
使用培养P.falciparum进行体外实验,研究RNA Pol III调制对寄生虫生长和病毒性基因表达的影响.
研究Plasmodium falciparum Maf1 (PfMaf1) 作为RNA Pol III转录的调节者的作用.

主要成果:

在干旱季节无症状个体的P. falciparum分离物中,RNA Pol III转录的下调.
确定了一种新型RNA Pol III依赖机制,可以控制寄生虫的增殖和毒性因子表达,以应对外部刺激.
塑菌 (Plasmodium falciparum Maf1) 被确定为RNA Pol III转录的关键调节器,对于细胞平衡和适应性反应都至关重要.

结论:

RNA Pol III转录的下调与季节性无症状疟疾感染有关.
这些发现揭示了P. falciparum细胞粘附,Pol III转录的非编码RNA和毒性之间的联系.
pfMaf1作为P. falciparum毒性和适应的关键调节者,为疟疾病原体提供了新的见解.

关键词:

在P. falciparum的研究中.传染病是一种传染性疾病.疟疾疟疾是一种疾病.微生物学的微生物.这是一个ncRNARNA.有的基因有的基因.毒性毒性是一种毒性.

更多相关视频

CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum

CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum

Published on: September 18, 2018

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

相关概念视频

Eukaryotic RNA Polymerases

Eukaryotic RNA Polymerases

RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...

Bacterial RNA Polymerase

Bacterial RNA Polymerase

Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...

Chromatin Structure Regulates pre-mRNA Processing

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...